Glioblastoma: From Diagnosis to Treatment

Glioblastoma, also known as GBM, represent 14.9% of all primary brain tumors, and 55.4% of all gliomas. GBM has the highest number of cases of all malignant tumor and has a median survival rate of about 15 months. Patients and family member of a GBM diagnosis have so many questions that can go unanswered. This month’s ABTA webinar focuses on this topic from a patient perspective and discusses the entire journey from the first diagnosis to treatment and prognosis. Dr. Merrell of NorthShore Neurological Institute will elaborate on innovative treatments for GBM including minimally invasive surgery and the latest clinical trials.

Видео Glioblastoma: From Diagnosis to Treatment канала American Brain Tumor Association